App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship – a multicentric randomized controlled trial
Article in Frontiers in Oncology (April 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes
Article in JMIR Cancer (April 2024)
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes (Preprint)
Preprint in JMIR Preprints (November 2023)